Impedimed

Impedimed

Impedimed

The world leader in the development and distribution of medical devices utilizing bioimpedance spectroscopy (BIS).
Founded
1999
Raised
$57M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$57,000,000
Post-IPO equity - 2016
Team Size
10+
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Impedimed makes some noise.